Urology · Aventura, FL
NPI
1144284688
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
21150 Biscayne Blvd, 404
Aventura, FL, 33180
Phone (305) 466-9111
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
1,005 services
Medicare patients, 2024
250
Average age 75
Drug cost, 2024
$1.7M
2,326 prescriptions
Company payments, 2025
$2,248
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark H Christ was code 81002 (clinical chemistry), 226 times for 155 patients. In total Mark H Christ billed 1,005 services in 55 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 226 | 155 | $3.41 | $771 |
| 51798 Ultrasound - Nonspecific | Office | 167 | 122 | $9.34 | $1,560 |
| 99214 Office E&M - Established | Office | 166 | 122 | $104.98 | $17K |
| 99213 Office E&M - Established | Office | 65 | 55 | $72.60 | $4,719 |
| 99212 Office E&M - Established | Office | 40 | 34 | $45.99 | $1,840 |
| 52000 Cystourethroscopy | Office | 26 | 22 | $212.06 | $5,514 |
| 99204 Office E&M - New | Office | 21 | 21 | $127.38 | $2,675 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 17 | 16 | $41.30 | $702 |
| 76872 Ultrasound - Nonspecific | Office | 16 | 16 | $103.52 | $1,656 |
| 55700 Other Organ Systems | Office | 14 | 14 | $220.52 | $3,087 |
By year: 2022 $95K for 2,026 services; 2023 $86K for 1,334 services; 2024 $68K for 1,005 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 226 | 155 | $3.41 | $771 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark H Christ prescribed most often to Medicare patients was Tamsulosin Hcl, with 598 prescriptions and refills. In total Mark H Christ wrote 2,326 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 598 | 1,744 | 281 | $9,219 |
| Finasteride Generic | 180 | 527 | 76 | $2,422 |
| Lupron Depot Leuprolide Acetate | 154 | 441 | 79 | $924K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 151 | 152 | 120 | $2,510 |
| Sildenafil Citrate Generic | 149 | 174 | 53 | $544 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 127 | 127 | 103 | $992 |
| Ciprofloxacin Hcl Generic | 103 | 103 | 87 | $1,137 |
| Gemtesa Vibegron | 85 | 165 | 37 | $77K |
| Myrbetriq Mirabegron | 82 | 176 | 37 | $79K |
| Methenamine Hippurate Generic | 79 | 165 | 33 | $4,034 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 56 | 128 | 25 | $1,450 |
| Bicalutamide Generic | 51 | 125 | 20 | $2,733 |
| Trelstar Triptorelin Pamoate | 48 | 140 | 21 | $121K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 46 | 46 | 38 | $193 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 43 | 115 | 24 | $854 |
Brand drugs: - claims; generic drugs: 1,845 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark H Christ $2,248 ($2,248 in general payments such as food, travel and fees) from 19 companies. The largest payer was Calyxo, Inc. with $1,225.
| Company | Payments | Amount |
|---|---|---|
| Calyxo, Inc. | 6 | $1,225 |
| Boston Scientific Corporation BSX | 4 | $177 |
| Janssen Biotech, Inc. JNJ | 5 | $155 |
| Verity Pharmaceuticals Inc. | 5 | $105 |
| Myriad Genetic Laboratories, Inc. MYGN | 4 | $95.14 |
| Ferring Pharmaceuticals Inc. | 3 | $77.93 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $51.78 |
| Profound Medical Corp. PROF | 2 | $48.11 |
| Abbvie Inc. ABBV | 2 | $41.41 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $40.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.